Navigation Links
MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
Date:4/29/2010

DALLAS, Texas, April 29, 2010 /PRNewswire/ -- According to a new market research report, 'global oncology biomarker market', published by MarketsandMarkets (http://www.marketsandmarkets.com), The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The Global Oncology Biomarkers Market report analyzes the oncology biomarkers diagnostics and discovery market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the oncology biomarkers market.

Browse more than 45 market data tables and in-depth TOC on Global Oncology Biomarkers Market. Early buyers will receive 10% customization of reports. http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The key factors driving the growth of the overall oncology biomarkers market include the rising prevalence of cancer across the globe; and the early diagnosis and enhanced testing capabilities biomarkers facilitate. Further, U.S. government initiatives and increasing patient awareness are also enhancing market growth.

Market players are now focusing on new product and consolidations to enhance their commercial portfolios. The most common strategies adopted by market players include agreement and collaborations to stabilize management costs and to take advantage of the core competencies of the partner company.

SCOPE AND FORMAT

The report analyzes the Oncology biomarkers market into the following segments:

    - Oncology biomarkers discovery market
    - Oncology biomarkers diagnostics market

The market data consists of aggregate sales figures of all oncology biomarkers submarkets. It analyzes the market aspects of products and services; sourcing key market developments from the top companies that it profiles.

Analyst Briefing Presentation on the Global Oncology Biomarkers Market to Be Held On 18th May 2010

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global oncology biomarkers market (http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html)

to be held on 18th May 2010. The briefing on the Global Oncology Biomarkers market (2009-2014) will benefit the biomarker technology providers, biopharma associations and forums and pharmaceutical companies.

To register your participation, please click here http://www.marketsandmarkets.com/AnalystBriefing/oncology-biomarker -market.asp

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

About us

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com
    http://www.marketsandmarkets.com


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
2. MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
3. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
4. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
5. Global Experts Explore Entire Spectrum of Aids Vaccine Development
6. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
7. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
8. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
9. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
10. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
11. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
Breaking Biology News(10 mins):